Skip to main content
Caplight Logo









PhiSkin

PhiSkin

Private
ShanghaiHealthcare & Life Scienceshttps://www.phiskin.com/

Last Round

Series B

Jun 7, 2017

Total Funding Raised

$27.2M

Company Overview

PhiSkin operates in Healthcare & Life Sciences and is based in Shanghai. Its latest recorded funding round was a Series B round in June 2017.

PhiSkin is a healthcare services company that operates a chain of aesthetic medical clinics in China providing non-surgical cosmetic and skin management treatments.

Sector

Healthcare & Life Sciences

Verticals

Fashion & Beauty

Business Model

B2C

Customer Profile

Services & Consulting

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

PhiSkin Comparables

Compare PhiSkin with similar companies based on industry and business-model similarity.

PhiSkin comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
EverCare (Beijing) Holding Group Co., Ltd.
85%
Mylike Medical Cosmetology Group
83%
Raily Aesthetic Medicine International Holdings
83%
Book a demo to see all comparables

For institutional investors. Book with your work email.

PhiSkin Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BJun 7, 2017
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

PhiSkin Investors

Notable investors and investment history

PhiSkin investors
InvestorRounds
H&Q Asia PacificSeries A
Legend CapitalSeries B
Ares Management CorporationSeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 7, 2017

    $17M round led by Legend Capital.

Book a demo to see all signals

For institutional investors. Book with your work email.

PhiSkin Filings

Explore SEC and related filing metadata, where available.

PhiSkin filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about PhiSkin's valuation, stock price, and market status.

Is PhiSkin a public or private company?

PhiSkin is a private company.

What is the current stock price of PhiSkin?

PhiSkin is a private company, so its shares have no public market price. Caplight tracks PhiSkin's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is PhiSkin worth (valuation)?

Valuation information for PhiSkin is not publicly available.

Can I buy PhiSkin stock?

PhiSkin shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was PhiSkin's last funding round?

PhiSkin's most recent funding round was Series B on June 7, 2017.

Who are the main investors in PhiSkin?

Key investors in PhiSkin include H&Q Asia Pacific, Legend Capital.

Will PhiSkin IPO soon?

No public IPO plans have been announced for PhiSkin.

How can I track PhiSkin secondary market activity?

Caplight tracks bids, offers, and trades in PhiSkin's shares on secondary markets.

Firmographic Details

HeadquartersShanghai
Employee Range23
Year Founded2012
Last FundingJun 7, 2017

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?